Parth Khanna is ACTO’s Chief Executive Officer and Founder, and improving treatment access by disrupting how drugs and devices are commercialized globally. His undergraduate degree in neuropsychology, two law degrees, and US patents in AI and NLP-based enterprise technologies have uniquely positioned him to address the changing needs of the life sciences industry. In 2014, Parth worked with Kapil Kalra and Kumar Erramilli, my roommates from the University of Waterloo, to build ACTO. He was selected as an EY Entrepreneur of the Year finalist in 2018 and awarded an international 30 Under 30 Honor Award in 2017.
At ACTO, Parth works with a talented, mission-driven team to solve the life sciences commercialization challenge and build a customer-centric organization. They have brought together a diverse network of investors, customers, and partners with a collective vision to leverage technology and field data to effectively communicate the clinical evidence stories of patient-centric technologies. In just a few years, ACTO has digitally transformed over 50 life sciences companies and achieved over 2970% revenue growth.
This speaker's sessions: